Abiopharma

New Form S-8 - XPLR Infrastructure, LP <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212449 <b>Size:</b> 190 KB

New Form FWP - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001214659-26-005745 <b>Size:</b> 119 KB

New Form S-8 POS - IN8BIO, INC. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212447 <b>Size:</b> 66 KB

New Form SCHEDULE 13G/A - Cayson Acquisition Corp <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001628280-26-032335 <b>Size:</b> 116 KB

New Form S-8 POS - IN8BIO, INC. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212444 <b>Size:</b> 66 KB

New Form S-3 - Jade Biosciences, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212443 <b>Size:</b> 514 KB

New Form 424B2 - NOMURA HOLDINGS INC <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057292 <b>Size:</b> 1 MB

New Form S-8 POS - IN8BIO, INC. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212441 <b>Size:</b> 66 KB

The company’s liability balance as of March 31, 2026, by maturity dates

New Form FWP - V2X, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057290 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - Fortress Value Acquisition Corp. V <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001213900-26-053423 <b>Size:</b> 14 KB

New Form S-8 - IN8BIO, INC. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001193125-26-212434 <b>Size:</b> 222 KB

New Form SCHEDULE 13G/A - DIEBOLD NIXDORF, Inc <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001644956-26-000016 <b>Size:</b> 6 KB

New Form S-8 - Edgewise Therapeutics, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001104659-26-057287 <b>Size:</b> 253 KB

Deadline Approaching: FS KKR Capital Corp. (FSK) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith